Autolus Therapeutics plc ADR (NASDAQ:AUTL) price on Thursday, April 10, fall -5.79% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $1.14.
A look at the stock’s price movement, the close in the last trading session was $1.21. Turning to its 52-week performance, $5.43 and $1.13 were the 52-week high and 52-week low respectively. Overall, AUTL moved -42.42% over the past month.
Autolus Therapeutics plc ADR’s market cap currently stands at around $303.38 million, with investors looking forward to this quarter’s earnings report slated for in May.
The average forecast suggests down to a -84.24% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 35.55M, representing a 251.28% jump on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that AUTL is a 100% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
3 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 3 recommend AUTL as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
AUTL’s current price about -27.10% and -36.92% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 27.32, while 7-day volatility ratio is 14.09% and 9.88% in the 30-day chart. Further, Autolus Therapeutics plc ADR (AUTL) has a beta value of 1.80, and an average true range (ATR) of 0.15. Analysts have given the company’s stock an average 52-week price target of $7.6, forecast between a low of $7.6 and high of $7.6. Looking at the price targets, the low is -566.67% off current price level while to achieve the yearly target high, price needs to move -566.67%. Nonetheless, investors will most likely welcome a -566.67% jump to $7.6 which is the analysts’ median price.
If we refocus on Autolus Therapeutics plc ADR (NASDAQ:AUTL), historical trading data shows that trading volumes averaged 1.37 million over the past 3 months. The company’s latest data on shares outstanding shows there are 266.13 million shares.
The 9.70% of Autolus Therapeutics plc ADR’s shares are in the hands of company insiders while institutional holders own 54.52% of the company’s shares. Current price change has pushed the stock -51.49% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the AUTL stock continues to rise going into the next quarter.
